What Is The Difference Between TIR And RETA?
TIR, also known as Tirzepatide, works as a dual-receptor agonist. It binds to and activates two key receptors: the GIP receptor and the GLP‑1 receptor. These two pathways work together to regulate metabolic signaling inside the body. This dual-action mechanism is well known and widely explored. It delivers a balanced signaling profile and has been a very popular option for a long time.
RETA, or Retatrutide, is an advanced triple-receptor agonist. Beyond GIP and GLP‑1, it additionally activates the glucagon receptor. Adding the glucagon pathway creates a completely different signaling pattern. The three pathways interact together, bringing a stronger and distinct metabolic signal profile compared with TIR.
Simply put, the main difference comes down to their target receptors. TIR relies on the dual GIP/GLP‑1 combination, while RETA uses three interrelated receptor pathways. They each have their own unique signaling characteristics, so you can choose based on which profile you are looking for.
